(Q37607090)

21 August 2017

title

Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses (English)

1 reference

21 August 2017

1 reference

1 reference

A Guay

1

1 reference

21 August 2017

A D Seftel

series ordinal

2

1 reference

21 August 2017

A Traish

series ordinal

3

1 reference

21 August 2017

publication date

1 October 2009

1 reference

International Journal of Impotence Research

21 August 2017

published in

1 reference

21 August 2017

volume

22

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

9-19

1 reference

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Male hypogonadism. Part I: Epidemiology of hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Male andropause: myth, reality, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Testosterone concentration in young patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Gonadal dysfunction in systemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Characterization of patients in a medical endocrine-based center for male sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Transient hypogonadotropic hypogonadism caused by critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Pituitary-testicular axis dysfunction in burned men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Transient hypogonadotrophic hypogonadism after head trauma: effects on steroid precursors and correlation with sympathetic nervous system activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Hypothalamic dysfunction in overtrained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Low levels of androgens in men with erectile dysfunction and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Suppression of plasma testosterone levels and psychological stress. A longitudinal study of young men in Officer Candidate School

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Androgen responses to stress. II. Excretion of testosterone, epitestosterone, androsterone and etiocholanolone during basic combat training and under threat of attack

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Weight loss in amateur wrestlers and its effect on serum testosterone levels

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Effect of immobilization stress on testosterone and inhibin in male rats

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.46

7 January 2021

Identifiers

DOI

10.1038/IJIR.2009.46

1 reference

21 August 2017

1 reference